Abstract
We studied the correlation between response to fluvoxamine and serotonin transporter gene promoter region polymorphism (5-HTTLPR). Eighteen children with autistic disorder completed a 12-week double-blind, placebo-controlled, randomized crossover study of fluvoxamine. Behavioral assessments were obtained before and at 12 weeks of treatment. 5-HTTLPR (long (l) or short(s)), was analyzed by the PCR method. Ten out of 18 patients responded to fluvoxamine treatment; allele type analysis revealed that clinical global effectiveness was noted significantly more in the l allele than in the s allele. However, with respect to language use, a significant effectiveness was noted in the s allele. 5-HTTLPR may influence the individual responses to fluvoxamine administration.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
G. M. Anderson F. C. Feibel L. A. Wetlaufer t. K. R. Schlich S. M. Ort D. J. Cohen (1985) ArticleTitleEffect of meal on human whole blood serotonin Gastroenterology 88 86–89
G. M. Anderson D. X. Freedman D. J. Cohen F. R. Volkmar E. L. Hoder P. McPhedran R. B. Minderaa C. R. Hansen J. G. Young (1987) ArticleTitleWhole blood serotonin in autistic and normal subjects Journal of Child Psychology and Psychiatry 28 885–900
D. C. Chugani O. Muzik R. Rothermel M. Behen P. Chakraborty T. Mangner E. A. da Silva H. T. Chugani (1997) ArticleTitleAltered serotonin synthesis in the dentatothalamocortical pathway in autistic boys Annals of Neurology 42 666–669
D. C. Chugani O. Muzik M. Behen R. Rothermel J. J. Janisse J. Lee H. T. Chugani (1999) ArticleTitleDevelopmental changes in brain serotonin synthesis capacity in autistic and nonautistic children Annals of Neurology 45 287–295
E. H. Cook (1990) ArticleTitleAutism: review of neurochemical investigation Synapse 6 292–308
E. H. Cook B. L. Leventhal (1996) ArticleTitleThe serotonin system in autism Current Opinion in Pediatrics 8 348–354
E. H. Cook SuffixJr. R. Courchesne C. Lord N. J. Cox S. Yan A. Lincoln R. Haas E. Courchesne B. L. Leventhal (1997) ArticleTitleEvidence of linkage between the serotonin transporter and autistic disorder Molecular Psychiatry 2 247–250
G. R. DeLong L. A. Teague M. M. Kamran (1998) ArticleTitleEffects of fluoxetine treatment in young children with idiopathic autism Developmental Medicine and Child Neurology 40 551–562
G. R. DeLong (1999) ArticleTitleAutism: new data suggest a new hypothesis Neurology 52 911–916
C. T. Gordon R. C. State J. E. Nelson S. D. Hamburger J. L. Rapoport (1993) ArticleTitleA double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder Archives of General Psychiatry 50 441–447
A. Heils A. Teufel S. Petri G. Stober P. Riederer D. Bengel K. P. Lesch (1996) ArticleTitleAllelic variation of human serotonin transporter gene expression Journal of Neurochemistry 66 2621–2624
H. Ishiguro T. Arinami K. Yamada Y. Otsuka M. Toru H. Shibuya (1997) ArticleTitleAn association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population Psychiatry and Clinical Neuroscience 51 333–335
D. K. Kim S. W. Lim S. Lee S. E. Sohn S. Kim C. G. Hahn B. J. Carroll (1999) ArticleTitleSerotonine transporter gene polymorphism and antidepressant response Neuroreport 11 215–219
K. P. Lesch D. Bengel A. Heils S. Z. Sabol B. D. Greenberg S. Petri J. Benjamin C. R. Muller D. H. Hamer D. L. Murphy (1996) ArticleTitleAssociation of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 274 1527–1531
K. Y. Little D. P. McLaughlin L. Zhang C. S. Livermore G. W. Dalack P. R. McFinton Z. S. DelProposto E. Hill B. J. Cassin S. J. Watson E. H. Cook (1998) ArticleTitleCocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels American Journal of Psychatry 155 207–213
C. J. McDougle L. H. Price W. K. Goodman (1990) ArticleTitleFluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report Journal of Autism and Devlopmental Disorders 20 537–543
C. J. McDougle S. T. Naylor D. J. Cohen F. R. Volkmar G. R. Heninger L. H. Price (1996) ArticleTitleA double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Archives of General Psychiatry 53 1001–1008
R. Mehlinger W. A. Scheftner E. Poznanski (1990) ArticleTitleFluoxetine and autism Journal of American Academy of Child Adolescent Psychiatry 29 985
T. Nakamura T. Muramatsu Y. Ono S. Matsushita S. Higuchi H. Mizushima K. Yoshimura S. Kanba M. Asai (1997) ArticleTitleSerotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese American Journal of Medican Genetics 74 544–545
InstitutionalAuthorNameNational Institute of Mental Health. (1985) ArticleTitleRating scales and assessment instruments for use in pediatric psychopharmacology research Psychopharmacology Bulletin 21 839–843
B. G. Pollock R. E. Ferrell B. H. Mulsant S. Mazumdar M. Miller R. A. Sweet S. Davis M. A. Kirshner P. R. Houck J. A. Stack C. F. Reynolds D. J. Kupfer (2000) ArticleTitleAllelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression Neuropsychopharmacology 23 587–590
R. J. Schain D. X. Freedmann (1961) ArticleTitleStudies on 5-hydroxyindole metabolism in autistic and other mentally retarded children Jouranal of Pediatrics 58 315–320
E. Schopler R. J. Reichler R. F. Devellis K. Dafy (1980) ArticleTitleToward objective classification of childhood autism: Childhood Autism Rating Scale (CARS) Journal of Autism and Devlopmental Disorders 10 91–103
E. Smeraldi R. Zanardi F. Benedetti D. Di Bella J. Perez M. Catalano (1998) ArticleTitlePolymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine Molecular Psychiatry 3 508–511
B. A. Sproule C. A. Naranjo K. E. Brenmer P. C. Hassan (1997) ArticleTitleSelective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence Clinical Pharmacokinetics 33 454–471
N. Sugiyama H. Sugie Y. Igarashi M. Ito T. Fukuda (1998) ArticleTitleLow-dose levodopa therapy of autistic disorder: evaluation of clinical effectiveness No To Hattatsu 30 51–55
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sugie, Y., Sugie, H., Fukuda, T. et al. Clinical Efficacy of Fluvoxamine and Functional Polymorphism in a Serotonin Transporter Gene on Childhood Autism. J Autism Dev Disord 35, 377–385 (2005). https://doi.org/10.1007/s10803-005-3305-2
Issue Date:
DOI: https://doi.org/10.1007/s10803-005-3305-2